JNBA Financial Advisors’s Takeda Pharmaceutical TAK Stock Holding History

JNBA Financial Advisors’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.77K	Hold	173	–	–	﹤0.01%	685
2026 Q1	$3.2K	Hold	173	–	–	﹤0.01%	674
2025 Q4	$2.7K	Buy	+173	New	+$2.47K	﹤0.01%	646
2022 Q1	–	Sell	-120	Closed	-$2K	–	835
2021 Q4	$2K	Hold	120	–	–	﹤0.01%	757
2021 Q3	$2K	Hold	120	–	–	﹤0.01%	684
2021 Q2	$2K	Hold	120	–	–	﹤0.01%	638
2021 Q1	$2K	Hold	120	–	–	﹤0.01%	611
2020 Q4	$2K	Hold	120	–	–	﹤0.01%	569
2020 Q3	$2K	Hold	120	–	–	﹤0.01%	532
2020 Q2	$2K	Hold	120	–	–	﹤0.01%	523
2020 Q1	$2K	Hold	120	–	–	﹤0.01%	514
2019 Q4	$2K	Hold	120	–	–	﹤0.01%	571
2019 Q3	$2K	Hold	120	–	–	﹤0.01%	555
2019 Q2	$2K	Hold	120	–	–	﹤0.01%	613
2019 Q1	$2K	Buy	+120	New	+$2.42K	﹤0.01%	513

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

JNBA Financial Advisors's TAK Position: Q2 2026 in Review

JNBA Financial Advisors held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 173 shares worth $2.77K. The position accounts for ﹤0.01% of the portfolio, ranked #685.

JNBA Financial Advisors first reported a position in TAK in Q1 2019 and has held it in 15 quarters since. The position peaked at $3.2K in Q1 2026. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

JNBA Financial Advisors held 173 shares of Takeda Pharmaceutical worth $2.77K as of Q2 2026.
JNBA Financial Advisors left its Takeda Pharmaceutical share count unchanged in Q2 2026.
Takeda Pharmaceutical made up ﹤0.01% of JNBA Financial Advisors's portfolio in Q2 2026, its #685 holding.
JNBA Financial Advisors first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 15 quarters since.
JNBA Financial Advisors's Takeda Pharmaceutical position peaked at $3.2K in Q1 2026.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on JNBA Financial Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.